HAI on rise, not to worry, some players are actively pursuing the quest of minimizing the issues

HAI on rise, not to worry, some players are actively pursuing the quest of minimizing the issues.

We are referring to combined efforts of PDI and Sabic to find out the solution involving the results, that eventually minimizes the count of healthcare associated issues.

As per Cheryl Moran of PDI, in order to understand the compatibility issues between healthcare devices and disinfectants it is mandatory for Healthcare equipment, disinfectants manufacturers and healthcare providers to work together.

The duo intends to protect the patients from damaged or improperly disinfected devices, and are leaving no stone unturned to accomplish the same.

HAI was talk of the medtech world sometime back, with activities involving alliances such as PDI-Sabic, it is really a relief to see the some players are working to fix the broken healthcare ecosystem.




India’s new development on device pricing-Boon or Bane for Make In India?


India has been most watched emerging market for medical devices. Country houses right infrastructure, technical know-how, not to forget regulatory knowledge in comparison to all its peer nation involving China, Thailand, Taiwan, Malaysia and others.

The cherry on cake was PM Modi’s recent Make in India campaign which provides incentives to foreign manufacturers to manufacture in India and levy government support on tax and other reforms. Further, last year’s government eased policy to allow 100% FDI under the automatic route in this sector made the situation more favourable for Indian medtech industry.

Country houses right infrastructure, technical know-how, not to forget regulatory knowledge in comparison to all its peer nation involving China, Thailand, Taiwan, Malaysia and others.

This streamlined flow of activities witnessed a sudden break when government raised a concern demanding medical devices price capping. The authorities wanted essential medical devices that are flagged to critical care, to have their price contained in order to make the devices affordable for patients across country.

Teams flagged to the process are likely to sit on the same, and come to the conclusion of how they will balance patients and manufacturers expectation. While one requests for affordability other looks for making cash in order to promote innovation.

Governing bodies are stuck in dilemma, root cause of which comes from the fact seeded to price disparity between indigenous and foreign brands.Foreign manufacturers respond to this by putting the quality difference reason as explanation to higher price quotes.

Call on the final hearing is subjective, and has put the governing agencies at tough spot. As we await for the final call, the prevailing situation leaves a lot of room for discussion around what is ideal thing to do.

For more trends follow:

〈Medical Device Trends〉

Your On-line Trend Tracker

What is happening in medical device contract sterilization market?


Generally consolidated industry or service line are static in terms of their activities, however one medical sub category begs to differ. Category in reference is contract sterilization services. Since 2014, when Sterigenics made an announcement to acquire Nordion, this industry, represented by 4 prominent players has been creating noises via one or the other news releases.

Some of the activity focus of the players include: Expansion, Acquisition, Funding and Regulatory Battles

The moment you think of sterilization services, two of the prominent names that surface up are, Sterigenics and Steris. While both the companies have expressed their love for M&A by participating in billion dollars (or almost billion dollars) transactions, their appetite for expansion does not seem to seize.


Sterigenics has acquired close to 4 companies from 2014, one of which was Nordion , a buyout which involved cash transaction of USD 826 million. While the sterilization facilities of the company are spread across the globe, its growth focus has been global, a point well proven by its evenly spread M&A cash. That is, company not just shelled M&A cash in American market ( Latam) but also in European geography. In European region, the acquisition target was Gammarad, and in America it was CBE.

Analysing M&As, highlights a pattern which says that most of the acquisition targets were pure play focused at bolstering gamma sterilization capabilities. Be it Nordion, CBE or Gammarad , all acquisition had gamma sterilization moto flagged to it. Expansion on the other hand not just focused at gamma, but also touched base with ETO and other sterilization types. While Costa Rica expansion had ETO in mind, Memphis and Illinois focused on Gamma.


On one side Sterigenics was growing manifold through M&As and expansions, Steris was battling the only acquisition that it made in long-time. FTC was all over this mega merger amid two leading sterilization service provider. Steris breathed sigh of relief recently when US court denied FTC’s request to stop merger between the companies.


While the consolidation of already consolidated market troubles the buyer <Medical, Pharma and other business segments>, distress is getting build within the industry too. Cobalt-60 supply and Environmental agency request of forbidding ETO sterilization continuity, remains two important challenges that are likely to keep contract sterilization service provider on their toes. Until this sub sector reaches any sort of stability it would be difficult to comment on its growth rate and size. However recent figures state the contract sterilization services market was valued USD 1.5 billion for the year 2014.

Top medtech stories from previous day


Medical device trends brings you top 3 stories from previous day. As these features remained at the forefront in terms of tweets , views and discussions, we bring you quick snapshot of their content. Below are top three stories purely based on their social media coverage and popularity:

1. Brookings institution jolts down the roadmap for post market surveillance system :
Brookings institution under the purview of FDA touts a report outlining post marketing surveillance strategy for booming medical device industry. Report highlights points such as usage of patient data on public and private portals for medical device tracking. It intends to draw schemes similar to Sentinel Initiative ( Electronic system tracking Pharma Products ) for medical device sector.

2. TE connectivity expresses its seriousness in healthcare through Advanced Cath acquisition:
Connectivity has been long standing outsourcing partner of medical device OEMs , and it just goes to prove its commitment to  the sector by acquiring catheter manufacturer AdvancedCath.

3. CRE bacteria that goes by alias “Superbug” continues to haunt US healthcare system :
Close to 135 patients have been infected  with contaminated endoscope  from the period 2013 – 2014 as per article featured on fiercemedical. The bacteria to be blamed for the issue is CRE or Super bug. Some of the experts say to seek help from ethylene gas, as it is one of the most widely used decontaminating agent. Though OEMs like Olympus back the suggestion ,FDA frowns upon any sort of remedy around the same. Further it goes ahead and warns the healthcare of contamination chances even after adhering to all the standard protocols in par with manufacturer’s recommendation.

For more updates subscribe to Medical Device Trends

Medical Device Trends
Your Online Tracker